The principles of gene therapy for the nervous system.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Trends in Neurosciences

• Publication date

  1996-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0166-2236(96)89620-2PMID 8820867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene transfer and expression in progeny after intravenous DNA injection into pregnant mice

  1995cited by this paper
• Isolation, characterization, and use of stem cells from the CNS.

  1995cited by this paper
• Gene therapy and the brain.

  1995cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy.

  1995cited by this paper
• CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses.

  1995cited by this paper
• Gene therapy for mitochondrial DNA defects: is it possible?

  1995cited by this paper
• Transfecting neurons and glia in the rat using pH-sensitive immunoliposomes.

  1995cited by this paper
• Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption.

  1995cited by this paper
• Molecular Basis of Common Hereditary Motor and Sensory Neuropathies in Humans and in Mouse Models

  1995cited by this paper
• Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects.

  1995cited by this paper
• Gene delivery into the central nervous system by nasal instillation in rats.

  1995cited by this paper
• Adenovirus gene transfer causes inflammation in the brain.

  1995cited by this paper
• Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS).

  1995cited by this paper
• Gene therapy for neurological disorders.

  1994cited by this paper
• Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector.

  1994cited by this paper
• Adenoviral vectors as functional retrograde neuronal tracers.

  1994cited by this paper
• Transgenic and Knock‐out Mice: Models of Neurological Disease

  1994cited by this paper
• The T alpha 1 alpha-tubulin promoter specifies gene expression as a function of neuronal growth and regeneration in transgenic mice

  1994cited by this paper
• GFAP promoter directs astrocyte-specific expression in transgenic mice

  1994cited by this paper
• Adenovirus‐mediated gene transfer to murine retinal cells in vitro and in vivo

  1994cited by this paper
• Gene transfer and the expression of a foreign gene in vivo in post-mitotic neurons of the adult rat brain using the hemagglutinating virus of the Japan-liposome method.

  1994cited by this paper
• Astrogliosis in culture: III. Effect of recombinant retrovirus expressing antisense glial fibrillary acidic protein RNA

  1994cited by this paper
• Gene Therapy for the Treatment of Malignant Brain Tumors with In Vivo Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene/Ganciclovir System. Iowa Methodist Medical Center, Des Moines, Iowa

  1994cited by this paper
• Gene transfer to brain using herpes simplex virus vectors

  1994cited by this paper
• In vivo transfer of a marker gene to study motoneuronal development.

  1994cited by this paper
• Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

  1994cited by this paper
• Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease

  1994cited by this paper
• Gene Therapy for Cancer

  1994cited by this paper
• Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector.

  1994cited by this paper
• Redundant genes?

  1994cited by this paper
• Neuronal transfection in brain slices using particle-mediated gene transfer.

  1994cited by this paper
• Herpes simplex virus vectors and gene transfer to brain.

  1994cited by this paper
• In vivo and ex vivo gene transfer to the brain.

  1994cited by this paper
• Gene targeting and synaptic plasticity.

  1994cited by this paper
• Sustained expression of functional nerve growth factor in primary septo-hippocampal cell cultures by liposome-mediated gene transfer.

  1994cited by this paper
• Long-Term Behavioral Recovery in Parkinsonian Rats by an HSV Vector Expressing Tyrosine Hydroxylase

  1994cited by this paper
• High‐Efficiency Gene Transfer Mediated by Adenovirus‐Polylysine‐DNA Complexes

  1994cited by this paper
• Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system.

  1994cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Inherited Neuropathies: The Interface between Molecular Genetics and Pathology

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Gene delivery to spinal motor neurons.

  1993cited by this paper
• The basic science of gene therapy.

  1993cited by this paper
• Transfer of a foreign gene into the brain using adenovirus vectors

  1993cited by this paper
• Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter

  1993cited by this paper
• An adenovirus vector for gene transfer into neurons and glia in the brain

  1993cited by this paper
• Gene delivery into the brain using virus vectors

  1993cited by this paper
• Adenovirus vectors enter the brain.

  1993cited by this paper
• Postnatal gene transfer into the central nervous system.

  1993cited by this paper
• The use of herpes simplex virus vectors for gene therapy in neurological diseases.

  1993cited by this paper
• Grafting in the mammalian central nervous system.

  1993cited by this paper
• A model system for in vivo gene transfer into the central nervous system using an adenoviral vector

  1993cited by this paper
• Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

  1993cited by this paper
• Gene therapy for neurologic disease.

  1993cited by this paper
• Intragenic regulatory elements contribute to transcriptional control of the neurofilament light gene.

  1992cited by this paper
• Genetic alteration of catecholamine specificity in transgenic mice.

  1992cited by this paper
• 5' flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice

  1992cited by this paper
• Persistence of plasmid DNA and expression in rat brain cells in vivo.

  1992cited by this paper
• Myelin acquisition in the central nervous system of the mouse revealed by an MBP-Lac Z transgene

  1992cited by this paper
• Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia.

  1992cited by this paper
• PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model.

  1991cited by this paper
• Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors.

  1991cited by this paper
• Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.

  1990cited by this paper
• Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

  1990cited by this paper
• Transneuronal transfer of herpes virus from peripheral nerves to cortex and brainstem.

  1989cited by this paper
• Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector.

  1989cited by this paper
• HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells

  1987cited by this paper
• A potential animal model for Lesch–Nyhan syndrome through introduction of HPRT mutations into mice

  1987cited by this paper
• Antisense Oligonucleotides as Therapeutic Agents Is the Bullet Really Magical ?

  year unknowncited by this paper

• Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases

  2021cites this paper
• Nanotechnology in Neuroscience and its Perspective as Gene Carrier.

  2017cites this paper
• Neuroplasmonics: From Kretschmann configuration to plasmonic crystals

  2016cites this paper
• Nanoparticles for sensing and potential gene therapy in neuroscience

  2012cites this paper
• ORMOSIL Nanoparticles: Nanomedicine Approach for Drug/Gene Delivery to the Brain

  2012cites this paper
• SIRNA GENE THERAPY FOR ALZHEIMER'S DISEASE TARGETING APP GENE

  2012cites this paper
• Nonviral gene transfection nanoparticles: function and applications in the brain.

  2008cites this paper
• NEURAL STEM/PROGENITOR CELLS IN THE POST-ISCHEMIC ENVIRONMENT: Proliferation, Differentiation and Neuroprotection

  2007cites this paper
• Efficient non‐viral transfection of adult neural stem/progenitor cells, without affecting viability, proliferation or differentiation

  2006cites this paper
• Gene therapy in neurological disease.

  2005cites this paper
• Ex vivo Gene Therapy and Cell Therapy for Stroke

  2005cites this paper
• Gene Therapy for the Treatment of Cancer

  2004cites this paper
• Adenovirus-mediated gene transfer into the brain stem to examine cardiovascular function: role of nitric oxide and Rho-kinase.

  2004cites this paper
• Use of gene therapy in central nervous system repair

  2004cites this paper
• Neuroprotective Role of a Proline-Rich Akt Substrate in Apoptotic Neuronal Cell Death after Stroke: Relationships with Nerve Growth Factor

  2004cites this paper
• In vivo transgene expression using an adenoviral tetracycline-regulated system with neuron-specific enolase promoter.

  2004cites this paper
• Gene therapy for stroke.

  2003cites this paper
• Transgenesis and the Study of Expression, Cellular Targeting and Function of Oxytocin, Vasopressin and Their Receptors

  2003cites this paper
• Gene therapy for psychiatric disorders.

  2003cites this paper
• Gene therapy for stroke.

  2003cites this paper
• PRODUCTION AND PURIFICATION OF HSV-1 VECTORS AND ITS USE FOR GENE TRANSFER TO HUMAN CD34⁺ CELLS

  2002cites this paper
• The magnocellular neuronal phenotype: cell-specific gene expression in the hypothalamo-neurohypophysial system.

  2002cites this paper
• Expression of recombinant adeno-associated virus in the brain of rats with a focal embolic stroke via carotid artery.

  2002cites this paper
• Functional Expression of Odorant Receptors of Zebrafish, Danio rerio

  2002cites this paper
• Cationic Liposome-Mediated GDNF Gene Transfer after Spinal Cord Injury

  2002cites this paper
• BDNF(brain-derived neurotrophic factor)の機械受容器における役割

  2002cites this paper
• Scaling-up The Production and Purification of HSV-based Gene Therapy Vectors and Development of GLP Assay System to Analyze Quantity and Quality of Clinical-grade HSV Vector Stocks

  2002cites this paper
• Characterization of Lentiviral Vector-Mediated Gene Transfer in Adult Mouse Brain

  2002cites this paper
• Gene therapy in tissue engineering

  2002cites this paper
• In vivo protein expression from mRNA delivered into adult rat brain.

  2001cites this paper
• Gene therapy strategies in neurodegenerative diseases.

  2001cites this paper
• Transgenic Models for Studies of Oxytocin and Vasopressin

  2001cites this paper
• Serotonergic gene expression and depression: implications for developing novel antidepressants.

  2001cites this paper
• Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system.

  2001cites this paper
• NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6‐OHDA rat model of Parkinson's disease

  2001cites this paper
• Encapsulated cell implants as a novel treatment for Parkinson's disease.

  2001cites this paper
• Effect of immunity on gene delivery into anterior horn motor neurons by live attenuated herpes simplex virus vector

  2001cites this paper
• Gene therapy for central nervous system repair.

  2001cites this paper
• Vasopressin gene expression: experimental models and strategies.

  2001cites this paper
• Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA, as a source of neural transplant material

  2001cites this paper
• Gene Therapy for Cerebrovascular Disease and Central Nervous System Trauma

  2001cites this paper
• Gene therapy strategies in neurodegenerative diseases.

  2001influential citation
• Helper-dependent adenovirus vectors: their use as a gene delivery system to neurons

  2000cites this paper
• Serotonergic gene transcriptional control regions: targets for antidepressant drug development?

  2000cites this paper
• Principles of gene therapy: potential applications in the treatment of cerebral ischaemia.

  2000cites this paper
• Neurotrophine und aktivitätsabhängige synaptische Plastizität: Untersuchungen zum Ort und Mechanismus der regulierten Neurotrophin-Freisetzung in adenoviral transduzierten hippokampalen Primärkulturen

  2000cites this paper
• Restorative surgery of the central nervous system by means of tissue engineering using NeuroGel implants

  2000cites this paper
• Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector

  2000cites this paper
• The decade of the brain: a brief review.

  2000cites this paper
• Encapsulated neural transplants.

  2000cites this paper
• Growth factor enhanced retroviral gene transfer to the adult central nervous system

  2000cites this paper
• Principles of gene therapy: potential applications in the treatment of cerebral ischaemia

  2000cites this paper
• Therapeutic Potential of Neurotrophic Factors and Neural Stem Cells Against Ischemic Brain Injury

  2000cites this paper
• Nonviral Glial Cell-Derived Neurotrophic Factor Gene Transfer Enhances Survival of Cultured Dopaminergic Neurons and Improves Their Function after Transplantation in a Rat Model of Parkinson’s Disease

  2000cites this paper
• Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression

  1999cites this paper
• Improved lipid-mediated gene transfer in C6 glioma cells and primary glial cells using FuGene.

  1999cites this paper
• Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon

  1999cites this paper
• [Friedreich's disease: a real spectrum of clinical manifestations in terms of direct DNA diagnosis].

  1999cites this paper
• Liposome-mediated NGF gene transfection following neuronal injury: potential therapeutic applications

  1999cites this paper
• Gene therapy for cerebrovascular disease.

  1999cites this paper
• Effective gene transfer of lacZ and P0 into Schwann cells of P0‐deficient mice

  1999cites this paper
• Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the Mitf(vit) mouse using a lentiviral vector.

  1999cites this paper
• Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats.

  1999cites this paper
• Somatic gene therapy in animal models of Parkinson's disease.

  1999cites this paper
• Oligodendrocyte‐specific gene expression in mouse brain: Use of a myelin‐forming cell type–specific promoter in an adeno‐associated virus

  1999cites this paper
• Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.

  1999cites this paper
• Expression of NMDA receptor channel subunit proteins using baculovirus and herpesvirus vectors.

  1999cites this paper
• [Molecular biology and cerebrovascular diseases].

  1999cites this paper
• The influence of interleukin-1 receptor antagonist transgene on spiral ganglion neurons.

  1999cites this paper
• Gene transfer to the brain: emerging therapeutic strategy in psychiatry?

  1999cites this paper
• Advances in Research on Neurodegeneration

  1999cites this paper
• Quantitative pathology in astrocytic tumors

  1999cites this paper
• Trophic Factors in Experimental Models of Adult Central Nervous System Injury

  1999cites this paper
• Ageing population in the developed countries: some ethical consequences

  1999cites this paper
• Potential therapeutic targets for schizophrenia

  1999cites this paper
• Liposome-Mediated Gene Transfer into Established CNS Cell Lines, Primary Glial Cells, and in Vivo

  1998cites this paper
• Gene Therapy of Huntington’s Disease

  1998cites this paper
• Vasopressin and Oxytocin

  1998cites this paper
• The role of neuronal growth factors in neurodegenerative disorders of the human brain.

  1998cites this paper
• Potential and limitations of a γ34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS

  1998cites this paper
• Neurometabolic disease.

  1998cites this paper
• Manipulation of gene expression in the mammalian nervous system: application in the study of neurite outgrowth and neuroregeneration-related proteins.

  1998cites this paper
• Liposome-mediated gene transfer into established CNS cell lines, primary glial cells, and in vivo.

  1998cites this paper
• Temporal profile of adenovirus-mediated E. coli lacZ gene expression in normal and post-ischemic gerbil hippocampus and ventricle.

  1998cites this paper
• Cortical interneurons upregulate neurotrophins in vivo in response to targeted apoptotic degeneration of neighboring pyramidal neurons.

  1998cites this paper
• Neuroantibodies: The Use of Recombinant Antibody Expression in the Central Nervous System

  1998cites this paper
• Retrovirus Vectors and Regulatable Promoters

  1998cites this paper
• Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade

  1998cites this paper
• Suppression of inflammation by dexamethasone prolongs adenoviral vector-mediated transgene expression in the facial nucleus of the rat.

  1998cites this paper
• Cell-specific gene expression in oxytocin and vasopressin magnocellular neurons.

  1998cites this paper
• Adenovirus-Mediated In Vivo Gene Transfer in Guinea Pig Middle Ear Mucosa

  1998cites this paper
• Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS.

  1997cites this paper
• Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complications.

  1997cites this paper
• Gene Expression Induced by Cerebral Ischemia: An Apoptotic Perspective

  1997cites this paper
• Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.

  1997cites this paper
• In vivo adenovirus-mediated gene transfer and the expression in ischemic and reperfused rat brain.

  1997cites this paper
• Adenovirus-mediated transfer of a functional GAD gene into nerve cells: potential for the treatment of neurological diseases

  1997cites this paper
• Gene Therapy for Central Nervous System Injury: The Use of Cationic Liposomes: An Invited Review

  1997cites this paper
• Cell culture models of interspecies selectivity to organophosphorous insecticides.

  1997cites this paper
• Regulated expression of the diphtheria toxin A gene in human glioma cells using prokaryotic transcriptional control elements.

  1997cites this paper